As a common blinding eye disease, cataract is more common in the elderly, and it is also one of the common complications in the diabetic population, which has a serious impact on the daily life of patients. With the continuous improvement of medical level and the increase of people's requirements for quality of life, the treatment of diabetes with cataract has gradually attracted widespread attention. Phacoemulsification, as one of the most effective surgical methods in clinical treatment of cataract, has the clinical advantages of rapid healing, fewer complications and small incision. Most clinical studies have confirmed its clinical effectiveness. Based on this, this study conducted a meta-analysis of related clinical studies on phacoemulsification in the treatment of diabetes with cataract, so as to provide a theoretical basis for subsequent clinical treatment. The results of meta-analysis show that phacoemulsification technology can significantly improve the clinical efficacy, improve visual acuity and reduce adverse reactions in patients with diabetes complicated with cataract, which provides a safe and effective surgical method for further improving the prognosis of such patients.

Lvyan Fu. Effect of phacoemulsification combined with visual acuity and adverse reactions in diabetic patients with cataract a meta-analysis. Frontiers in Medical Science Research (2023) Vol. 5, Issue 6: 20-27. https://doi.org/10.25236/FMSR.2023.050604.

[1] Meigs JB. The Genetic Epidemiology of Type 2 Diabetes: Opportunities for Health Translation. Curr Diab Rep. 2019 Jul 22; 19(8):62. 

[2] Ma RCW. Epidemiology of diabetes and diabetic complications in China. Diabetologia. 2018 Jun; 61(6):1249-1260.

[3] Juan J, Yang H. Prevalence, Prevention, and Lifestyle Intervention of Gestational Diabetes Mellitus in China. Int J Environ Res Public Health. 2020 Dec 18; 17(24):9517. 

[4] Kelkar A, Kelkar J, Mehta H, et al. Cataract surgery in diabetes mellitus: A systematic review. Indian J Ophthalmol. 2018 Oct; 66(10):1401-1410. 

[5] Khan A, Petropoulos IN, Ponirakis G, et al. Visual complications in diabetes mellitus: beyond retinopathy. Diabet Med. 2017 Apr; 34(4):478-484.

[6] Jeong IS, Lee EJ, Kim MS, et al. Incidence and Predictors of Cataract among People with Type 2 Diabetes Mellitus: Using Secondary Data Analysis from the Ansan Cohort of the Korean Genome and Epidemiology Study. J Korean Acad Nurs. 2022 Feb; 52(1):24-35.

[7] Nyström A, Almarzouki N, Magnusson G, et al. Phacoemulsification and primary implantation with bag-in-the-lens intraocular lens in children with unilateral and bilateral cataract. Acta Ophthalmol. 2018; 96: 364–370.

[8] Takahashi T, Okamoto T, Yokota I, et al. The effect of rituximab on the quality of life of children with refractory nephrotic syndrome [J]. Pediatr Int. 2022; 64 (1):e14725.

[9] Chen Xiaojun, Gao Yongjie, Wang Baozhen. Effects of phacoemulsification on retinal thickness and vessel density in macular region [J]. Liaoning Medical Journal, 2021, 35(5):53-55.

[10] Fang Y. Phacoemulsification alone and vitrectomy in the treatment of diabetic retinopathy with cataract [J]. Modern Medicine and Health, 2020, 36(11):1715-1717.

[11] Li Xianfeng. Effect of phacoemulsification combined with intraocular lens implantation in the treatment of diabetic cataract [J]. Clinical Medicine Practice, 2019, 28(3):184-186.

[12] Mao Yihui, Chen Xi. Effect of phacoemulsification combined with Angle separation in the treatment of diabetic cataract with angle-closure glaucoma [J]. Chinese Modern Doctor, 2020, 58(35): 58-61.

[13] Song Yu, Lu Jun, Li Hong. Clinical efficacy and safety of phacoemulsification and intraocular lens implantation combined with intravitreal injection of anti-vascular endothelial growth factor drugs in patients with cataract and diabetic retinopathy [J]. J Clinical Rational Drug Use, 2022, 15(12):149-151.

[14] Tang L, Zhang M. The efficacy of ultrasonic emulsification with IOL implantation in patients with primary angle-closure glaucoma combined with cataract. Am J Transl Res. 2021 Jul 15; 13(7): 7874-7881.

[15] Wang Jia. Effect of phacoemulsification combined with intraocular lens implantation on diabetic patients with cataract [J]. Journal of Clinic & Pathology, 2021, 41(2):333-339. 

[16] Yuan Yuan, Chen Xupan, Chen Lan. Changes of macular retinal thickness and its effect on visual acuity after phacoemulsification and intraocular lens implantation in diabetic cataract [J]. Current Medicine, 2020, 26(4):93-95.

[17] Zhang Xiaolan, Chen Shengju. Clinical observation of phacoemulsification and intraocular lens implantation in diabetic patients [J]. Journal of Clinical Medicine Electronic Literature, 2020, 7(95):14, 16.

[18] Lai KR, Zhang XB, Yu YH, et al. Comparative clinical outcomes of Tecnis toric IOL implantation in femtosecond laser-assisted cataract surgery and conventional phacoemulsification surgery. Int J Ophthalmol. 2020; 13: 49–53. 

[19] Topaloğlu R, Gülhan B, Çelegen K, et al. Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth. Front Pediatr[J]. 2019; 7: 313.

[20] Sorkin N, Kreimei M, Einan-Lifshitz A, et al. Stepwise combination of femtosecond astigmatic keratotomy with phacoemulsification and toric intraocular lens implantation in treatment of very high postkeratoplasty astigmatism. Cornea. 2020; 39: 71–76. 

[21] Onofre-Déciga PK, Palacio-Pastrana C, Solís-Hernández C, et al. Social impact indicators in patient diagnosed of senile cataract treated with phacoemulsification plus intraocular lens implantation. Cir Cir. 2020; 88: 331–336.